Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > NY Providers > Ophthalmologists

Dr. Szilard Kiss, MD

Accepting New Patients

(Szilard Kiss, M.D.)

(No ratings)

Specializes in: Ophthalmology (Eye Disease), Ocular Oncology and Vitreoretinal Diseases (Retina and Vitreous)

Columbia University, College of Physicians and Surgeons (2002)

Professional interests include: eye exam, uveitis, vasculitis, and more.

1305 York Avenue 11th Floor
New York, NY 10021

(646) 962-2020

Dr. Szilard Kiss, MD is an ophthalmologist in New York, NY specializing in ophthalmology (eye disease), ocular oncology and vitreoretinal diseases (retina and vitreous). He graduated from Columbia University, College of Physicians and Surgeons in 2002 and has 23 years of experience. Dr. Szilard Kiss, MD is affiliated with NewYork-Presbyterian, Weill Cornell Medicine, Israel Englander Department of Ophthalmology and WEILL MEDICAL COLLEGE OF CORNELL.

Office Locations

Address:

1305 York Avenue 11th Floor
New York, NY 10021

In The News (see more mentions in the news)

“"As a practicing physician with a deep understanding of the wet AMD patient population's needs, the longer duration of efficacy from weeks to years, as well as the favorable safety profile of...”—"Adverum Biotechnologies Presents Three-Year Aflibercept Protein Expression and Improvement in Anatomic Outcomes After a Single IVT Injection of ADVM-022 in the OPTIC Study in Wet AMD", Associated Press News, June 2022

“An encore of these data will be featured in an oral presentation on May 19, 2022 at ASGCT by Szilard Kiss, M.D., Bob and Dolores Hope - Robert M. Ellsworth, M.D. Distinguished Associate Professor...”—"Adverum Presents Data at ASGCT Further Supporting Phase 2 Development Plans for ADVM-022", Associated Press News, May 2022

“"These new data give us important insight into the high levels of efficacy that wet AMD patients experience following treatment with ADVM-022, particularly among those whose baseline levels of NAbs...”—"Adverum Biotechnologies Presents Additional Efficacy and Safety Data from the OPTIC Trial of ADVM-022 in Wet AMD at the ARVO 2022 Annual Meeting", Associated Press News, May 2022

diagnostic imaging	53
doctor visit	180
eye procedures	2825
injections	191
ultrasound (sonogram)	53

**Gender**
Male	174
Female	280

**Ethnicity**
Non-Hispanic White	235
Black	91
Hispanic	82
Asian	33
Other	13
Native American	0

**Age**
From 65 to 74	181
From 75 to 84	129
85 and over	66
Less than 65	78

Hypertension	66
High Cholesterol	56
Stroke	6
Ischemic Heart Disease	41
Depression	17
Chronic Kidney Disease	29
Asthma	9
Osteoperosis	10
Atrial Fibrilation	9
Heart Failure	20
Chronic Obstructive Pulmonary Disease	7
Diabetes	49
Dementia	9
Cancer	10

diagnostic imaging	29
doctor visit	112
eye procedures	2937
injections	207
ultrasound (sonogram)	29

**Gender**
Male	169
Female	290

**Ethnicity**
Non-Hispanic White	249
Black	80
Hispanic	84
Asian	29
Other	17
Native American	0

**Age**
From 65 to 74	186
From 75 to 84	137
85 and over	55
Less than 65	81

Hypertension	63
High Cholesterol	54
Stroke	7
Ischemic Heart Disease	41
Depression	17
Chronic Kidney Disease	31
Asthma	7
Osteoperosis	11
Atrial Fibrilation	7
Heart Failure	18
Chronic Obstructive Pulmonary Disease	7
Diabetes	47
Dementia	9
Cancer	14

diagnostic imaging	60
doctor visit	134
eye procedures	2996
injections	287
ultrasound (sonogram)	60

**Gender**
Male	362
Female	562

**Ethnicity**
Non-Hispanic White	564
Black	108
Hispanic	162
Asian	52
Other	38
Native American	0

**Age**
From 65 to 74	366
From 75 to 84	292
85 and over	136
Less than 65	130

Hypertension	62
High Cholesterol	56
Stroke	6
Ischemic Heart Disease	37
Depression	19
Chronic Kidney Disease	28
Asthma	7
Osteoperosis	11
Atrial Fibrilation	10
Heart Failure	16
Chronic Obstructive Pulmonary Disease	6
Diabetes	47
Dementia	10
Cancer	10

diagnostic imaging	113
doctor visit	183
eye procedures	3956
injections	418
ultrasound (sonogram)	113

**Gender**
Male	219
Female	340

**Ethnicity**
Non-Hispanic White	351
Black	70
Hispanic	81
Asian	34
Other	0
Native American	0

**Age**
From 65 to 74	232
From 75 to 84	171
85 and over	89
Less than 65	67

Hypertension	63
High Cholesterol	50
Stroke	6
Ischemic Heart Disease	35
Depression	19
Chronic Kidney Disease	33
Asthma	11
Osteoperosis	11
Atrial Fibrilation	10
Heart Failure	16
Chronic Obstructive Pulmonary Disease	8
Diabetes	43
Dementia	10
Cancer	11

diagnostic imaging	119
doctor visit	223
eye procedures	4589
injections	481
ultrasound (sonogram)	119

**Gender**
Male	246
Female	396

**Ethnicity**
Non-Hispanic White	404
Black	74
Hispanic	86
Asian	45
Other	0
Native American	0

**Age**
From 65 to 74	268
From 75 to 84	215
85 and over	87
Less than 65	72

Hypertension	61
High Cholesterol	43
Stroke	9
Ischemic Heart Disease	36
Depression	20
Chronic Kidney Disease	33
Asthma	6
Osteoperosis	11
Atrial Fibrilation	10
Heart Failure	15
Chronic Obstructive Pulmonary Disease	8
Diabetes	45
Dementia	9
Cancer	11

diagnostic imaging	96
doctor visit	415
eye procedures	5117
injections	504
ultrasound (sonogram)	96

**Gender**
Male	282
Female	486

**Ethnicity**
Non-Hispanic White	522
Black	78
Hispanic	88
Asian	44
Other	0
Native American	0

**Age**
From 65 to 74	319
From 75 to 84	255
85 and over	120
Less than 65	74

Hypertension	62
High Cholesterol	57
Stroke	6
Ischemic Heart Disease	35
Depression	19
Chronic Kidney Disease	30
Asthma	6
Osteoperosis	12
Atrial Fibrilation	9
Heart Failure	15
Chronic Obstructive Pulmonary Disease	10
Diabetes	39
Dementia	8
Cancer	13

diagnostic imaging	75
doctor visit	451
eye procedures	5768
injections	557
ultrasound (sonogram)	75

**Gender**
Male	337
Female	545

**Ethnicity**
Non-Hispanic White	593
Black	86
Hispanic	95
Asian	55
Other	0
Native American	0

**Age**
From 65 to 74	357
From 75 to 84	309
85 and over	131
Less than 65	85

Hypertension	64
High Cholesterol	62
Stroke	6
Ischemic Heart Disease	38
Depression	19
Chronic Kidney Disease	33
Asthma	7
Osteoperosis	14
Atrial Fibrilation	8
Heart Failure	16
Chronic Obstructive Pulmonary Disease	9
Diabetes	45
Dementia	9
Cancer	15

diagnostic imaging	55
doctor visit	1253
eye procedures	3457
injections	524
ultrasound (sonogram)	55

**Gender**
Male	280
Female	451

**Ethnicity**
Non-Hispanic White	503
Black	83
Hispanic	71
Asian	36
Other	38
Native American	0

**Age**
From 65 to 74	298
From 75 to 84	275
85 and over	100
Less than 65	58

Hypertension	57
High Cholesterol	56
Stroke	5
Ischemic Heart Disease	35
Depression	17
Chronic Kidney Disease	31
Asthma	5
Osteoperosis	13
Atrial Fibrilation	8
Heart Failure	17
Chronic Obstructive Pulmonary Disease	8
Diabetes	39
Dementia	10
Cancer	13

diagnostic imaging	125
doctor visit	3693
eye procedures	9264
injections	1425
ultrasound (sonogram)	125

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Szilard Kiss, MD for Medicare patients.

The highest averages for the top procedures that Dr. Szilard Kiss, MD treated as an ophthalmologist in New York, NY were eye procedures, injections, diagnostic imaging and ultrasound (sonogram).

diagnostic imaging	80
doctor visit	739
eye procedures	4546
injections	510
ultrasound (sonogram)	80

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Szilard Kiss, MD.

**Gender**
Female	335
Male	206

**Ethnicity**
Black / African American	67
Asian / Pacific Islander	32
Non-Hispanic White	342
Native American / Alaskan Native	0
Hispanic	74
Other	10

**Age**
85 and over	78
75 to 84	178
Less than 65	64
65 to 74	220

Average of Total of Conditions of Medicare patients treated by Dr. Szilard Kiss, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Szilard Kiss, MD treated were hypertension, high cholesterol, diabetes and ischemic heart disease.

Hypertension	49
High Cholesterol	43
Stroke	5
Ischemic Heart Disease	29
Depression	14
Chronic Kidney Disease	24
Asthma	5
Osteoporosis	9
Heart Failure	13
Chronic Obstructive Pulmonary Disease	6
Diabetes	35
Atrial Fibrillation	7
Cancer	9
Dementia	7

Education & Training

Dr. Szilard Kiss, MD graduated from Columbia University, College of Physicians and Surgeons in 2002. He completed residency at Columbia University Affiliated Hospitals. He is certified by the American Board of Ophthalmology and has a state license in New York.

Medical School: Columbia University, College of Physicians and Surgeons (2002)

Residency: Columbia University Affiliated Hospitals

Board Certification: American Board of Ophthalmology

Licensed In: New York

Affiliations & Hospitals

Dr. Szilard Kiss, MD is associated with these hospitals and organizations:

NewYork-Presbyterian

Weill Cornell Medicine

Israel Englander Department of Ophthalmology

WEILL MEDICAL COLLEGE OF CORNELL

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Szilard Kiss, MD appears to accept the following insurance providers: Health Insurance Plan of NY (HIP), United Healthcare, AETNA, Oxford Health Plans, Empire Blue Cross/Blue Shield Healthplus, GHI, Aetna - NYP, VNSNY CHOICE, EmblemHealth, Fidelis Care, Medicare Advantage, Affinity Health Plan, Medicare, Healthfirst, Medicaid, Cigna, United Healthcare Empire Plan, United Healthcare Compass, *, Freedom, Community Plan, Rockefeller University - Trustmark, Amida Care, HMO, EPO/POS, Blue Access, EPO, PPO, CBP, CHP, Metro/Core/Charter, Mediblue (Senior), WorldWide Medical and Liberty.

Insurance Accepted by Provider includes:

According to our sources, Dr. Szilard Kiss, MD accepts the following insurance providers:

Health Insurance Plan of NY (HIP)

United Healthcare

AETNA

Oxford Health Plans

Empire Blue Cross/Blue Shield Healthplus

GHI

Aetna - NYP

VNSNY CHOICE

EmblemHealth

Fidelis Care

Medicare Advantage

Affinity Health Plan

Medicare

Healthfirst

Medicaid

Cigna

United Healthcare Empire Plan

United Healthcare Compass

Freedom

Community Plan

Rockefeller University - Trustmark

Amida Care

HMO

EPO/POS

Blue Access

EPO

PPO

CBP

CHP

Metro/Core/Charter

Mediblue (Senior)

WorldWide Medical

Liberty

Show More

Ratings & Reviews

Dr. Szilard Kiss, MD does not have any reviews yet, be the first to leave a review of Dr. Szilard Kiss, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Szilard Kiss, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
optos plc	$344,400 Optos Scanning Laser Ophthalmoscope $139,206	scanning laser ophthalmoscope $60,782	P200TxE $15,400	P200DTx $4,356	P200Tx $223	Other $124,434
Regeneron Pharmaceuticals, Inc.	$157,343 EYLEA (aflibercept) Injection $84,929	EYLEA aflibercept injection $69,240	Eylea $3,174
Genentech USA, Inc.	$119,651 LUCENTIS $114,504	Non-Covered Product $5,147
Optos, Inc.	$90,458 California $35,430	scanning laser ophthalmoscope $22,342	P200Tx $13,743	P200TxE $1,000	$17,942
Allergan Inc.	$75,455 OZURDEX $71,182	LUMIGAN $90	RESTASIS $67	$4,116
Other	$172,365 LUCENTIS $31,662	Eylea $31,459	BMN 190 $25,300	ILUVIEN $12,039	EYLEA aflibercept injection $11,039	Other $60,866

**Types of Payments**
Consulting Fee	$464,801
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$256,675
Travel and Lodging	$153,527
Honoraria	$53,183
Education	$20,398
Other	$11,088

Research Payments

Dr. Szilard Kiss, MD has received 21 research payments totaling $175,587.

Ownership and Interest Payments

This table describes ownership payments received by Dr. Szilard Kiss, MD.

Merge Healthcare Incorporated

2015

$1,066.59

Physician Covered Recipient

exercise of stock options

Biography

Dr. Szilard Kiss works as an ocular oncology and vitreoretinal diseases (retina and vitreous). Dr. Kiss's clinical interests include diabetes, macular degeneration, and uveitis. His professional affiliations include Weill Cornell Medicine and NewYork-Presbyterian. He appears to be in-network for United Healthcare Compass, Health Insurance Plan of New York (HIP), Blue California, and more. Dr. Kiss welcomes new patients at his office in as reported by Weill Cornell Medicine. He is a graduate of Columbia University, College of Physicians and Surgeons. For his residency, Dr. Kiss trained at a hospital affiliated with Columbia University. Distinctions awarded to Dr. Kiss include: Honors and Awards; America's Top Ophthalmologists, Consumers' Research Council of America; and Named to Marquis Who's Who in America list.